Illumina whole-genome sequencing technology to accelerate rare disease testing in Florida
Go back to Illumina whole-genome sequencing technology to accelerate rare disease testing in Florida| Illumina, Inc. (NASDAQ: ILMN) | Delayed: 273.90 +18.52 (7.25%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $255.38 | 52 Week High | $196.47 | |||
| Open | $253.79 | 52 Week Low | $127.10 | |||
| Day High | $277.95 | P/E | 304.33 | |||
| Day Low | $250.92 | EPS | $0.90 | |||
| Volume | 3,480,182 | |||||
